Petco Health and Wellness Company, Inc.

NasdaqGS:WOOF Stock Report

Market Cap: US$1.1b

Petco Health and Wellness Company Valuation

Is WOOF undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of WOOF when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: WOOF ($4.17) is trading below our estimate of fair value ($5.5)

Significantly Below Fair Value: WOOF is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for WOOF?

Key metric: As WOOF is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for WOOF. This is calculated by dividing WOOF's market cap by their current revenue.
What is WOOF's PS Ratio?
PS Ratio0.2x
SalesUS$6.22b
Market CapUS$1.09b

Price to Sales Ratio vs Peers

How does WOOF's PS Ratio compare to its peers?

The above table shows the PS ratio for WOOF vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average4.6x
WINA Winmark
17.2x4.2%US$1.4b
SBH Sally Beauty Holdings
0.4x1.3%US$1.3b
EYE National Vision Holdings
0.4x-2.9%US$893.0m
HZO MarineMax
0.3x2.7%US$654.3m
WOOF Petco Health and Wellness Company
0.2x1.4%US$1.1b

Price-To-Sales vs Peers: WOOF is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (4.6x).


Price to Sales Ratio vs Industry

How does WOOF's PS Ratio compare vs other companies in the US Specialty Retail Industry?

44 CompaniesPrice / SalesEstimated GrowthMarket Cap
TA TravelCenters of America
0.1x-0.8%US$1.30b
ODP ODP
0.1x-2.1%US$778.86m
ARKO Arko
0.09x-1.7%US$766.41m
GCO Genesco
0.1x1.9%US$323.86m
WOOF 0.2xIndustry Avg. 0.4xNo. of Companies44PS00.61.21.82.43+
44 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: WOOF is good value based on its Price-To-Sales Ratio (0.2x) compared to the US Specialty Retail industry average (0.4x).


Price to Sales Ratio vs Fair Ratio

What is WOOF's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

WOOF PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.2x
Fair PS Ratio0.4x

Price-To-Sales vs Fair Ratio: WOOF is good value based on its Price-To-Sales Ratio (0.2x) compared to the estimated Fair Price-To-Sales Ratio (0.4x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst WOOF forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$4.17
US$3.74
-10.4%
31.9%US$5.50US$1.50n/a12
Nov ’25US$4.49
US$3.74
-16.8%
31.9%US$5.50US$1.50n/a12
Oct ’25US$4.47
US$3.45
-22.9%
29.0%US$5.00US$1.50n/a12
Sep ’25US$3.19
US$3.21
+0.6%
35.8%US$5.00US$1.00n/a12
Aug ’25US$3.17
US$3.21
+1.2%
35.8%US$5.00US$1.00n/a12
Jul ’25US$3.37
US$3.04
-9.7%
33.4%US$5.00US$1.00n/a12
Jun ’25US$3.86
US$2.96
-23.4%
32.9%US$5.00US$1.00n/a12
May ’25US$1.56
US$3.00
+92.1%
45.4%US$6.00US$1.00n/a14
Apr ’25US$2.08
US$3.25
+56.1%
42.6%US$6.00US$1.00n/a14
Mar ’25US$2.60
US$3.74
+43.8%
32.3%US$6.00US$1.00n/a14
Feb ’25US$2.48
US$3.74
+50.8%
32.3%US$6.00US$1.00n/a14
Jan ’25US$3.16
US$3.94
+24.6%
24.3%US$6.00US$2.75n/a14
Dec ’24US$3.46
US$4.19
+21.2%
30.6%US$7.00US$2.75n/a13
Nov ’24US$3.33
US$6.42
+92.9%
25.3%US$10.00US$4.00US$4.4913
Oct ’24US$4.09
US$6.62
+61.7%
22.4%US$10.00US$4.00US$4.4713
Sep ’24US$5.16
US$6.62
+28.2%
22.4%US$10.00US$4.00US$3.1913
Aug ’24US$7.99
US$9.88
+23.7%
17.3%US$12.00US$6.00US$3.1713
Jul ’24US$8.90
US$9.88
+11.1%
17.3%US$12.00US$6.00US$3.3713
Jun ’24US$7.50
US$9.82
+31.0%
17.0%US$12.00US$6.00US$3.8614
May ’24US$9.87
US$10.68
+8.2%
19.9%US$15.00US$7.00US$1.5614
Apr ’24US$9.00
US$11.12
+23.5%
28.3%US$20.00US$7.00US$2.0813
Mar ’24US$10.30
US$14.15
+37.4%
20.7%US$20.00US$9.00US$2.6013
Feb ’24US$12.09
US$14.08
+16.4%
20.9%US$20.00US$9.00US$2.4813
Jan ’24US$9.48
US$14.46
+52.5%
20.4%US$20.00US$9.00US$3.1613
Dec ’23US$11.09
US$14.85
+33.9%
23.2%US$22.00US$9.00US$3.4613
Nov ’23US$10.58
US$17.38
+64.3%
27.5%US$30.00US$10.00US$3.3313

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies